942 results on '"van der Bom, Johanna G."'
Search Results
2. Genetic variants, thrombocytopenia, and clinical phenotype of type 2B von Willebrand disease: a median 16-year follow-up study
3. Umbilical Cord Blood as an Alternative to Neonatal Blood for Complete Blood Count: A Comparison Study
4. Thromboembolic events in severe postpartum hemorrhage treated with recombinant activated factor VII: a systematic literature review and meta-analysis
5. Type 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studies
6. Darbepoetin alfa to reduce transfusion episodes in infants with haemolytic disease of the fetus and newborn who are treated with intrauterine transfusions in the Netherlands: an open-label, single-centre, phase 2, randomised, controlled trial
7. Natural history of human platelet antigen 1a-alloimmunised pregnancies: a prospective observational cohort study
8. Desmopressin in nonsevere hemophilia A: patient perspectives on use and efficacy
9. Patients’ and health care providers’ perspectives on quality of hemophilia care in the Netherlands: a questionnaire and interview study
10. Colorectal cancer screening in patients with inherited bleeding disorders: high cancer detection rate in hemophilia patients
11. In patients with hemophilia, a decreased thrombin generation profile is associated with a severe bleeding phenotype
12. Postnatal treatment for children with fetal and neonatal alloimmune thrombocytopenia: a multicentre, retrospective, cohort study
13. Desmopressin response depends on the presence and type of genetic variants in patients with type 1 and type 2 von Willebrand disease
14. SYMPHONY consortium: Orchestrating personalized treatment for patients with bleeding disorders
15. Socioeconomic participation of persons with hemophilia: Results from the sixth hemophilia in the Netherlands study
16. Patient‐reported data on the severity of Von Willebrand disease.
17. Disease severity in subsequent pregnancies with RhD immunization: A nationwide cohort
18. Efficacy and Safety Analyses of Recombinant Factor VIIa in Severe Post-Partum Hemorrhage
19. Incidence and mortality rates of intracranial hemorrhage in hemophilia: a systematic review and meta-analysis
20. Hepatitis C virus in hemophilia: Health‐related quality of life after successful treatment in the sixth Hemophilia in the Netherlands study
21. Treatment‐related risk factors for inhibitor development in non‐severe hemophilia A after 50 cumulative exposure days: A case‐control study
22. Perioperative pharmacokinetic-guided factor VIII concentrate dosing in haemophilia (OPTI-CLOT trial): an open-label, multicentre, randomised, controlled trial
23. Patient‐relevant health outcomes for hemophilia care: Development of an international standard outcomes set
24. Biological stratification of clinical disease courses in childhood immune thrombocytopenia
25. Mortality, life expectancy, and causes of death of persons with hemophilia in the Netherlands 2001–2018
26. A clinical prediction score for transient versus persistent childhood immune thrombocytopenia
27. Prophylactic Radiologic Interventions for Postpartum Hemorrhage Control in Women With Placenta Accreta Spectrum Disorder: A Systematic Review and Meta-analysis.
28. The factor VIII treatment history of non‐severe hemophilia A
29. ADAMTS‐13 and bleeding phenotype in von Willebrand disease
30. Prediction of Inhospital Mortality in Critically Ill Patients With Sepsis: Confirmation of the Added Value of 24-Hour Lactate to Acute Physiology and Chronic Health Evaluation IV
31. Laboratory approach for vaccine‐induced thrombotic thrombocytopenia diagnosis in the Netherlands
32. Challenging the dogma: Red blood cell‐directed autoimmunity as risk factor for red blood cell alloimmunisation after blood transfusion
33. Thrombocytopenia and the effect of platelet transfusions on the occurrence of intracranial hemorrhage in patients with acute leukemia – a nested case-control study
34. Type 1 VWD classification revisited - novel insights from combined analysis of the LoVIC and WiN studies
35. Challenging the dogma: Red blood cell-directed autoimmunity as risk factor for red blood cell alloimmunisation after blood transfusion
36. Transfusion of ever-pregnant donor red blood cells and mortality of male patients
37. The spectrum of neutralizing and non-neutralizing anti-FVIII antibodies in a nationwide cohort of 788 persons with hemophilia A
38. Description of mitochondrial oxygen tension and its variability in healthy volunteers
39. Donor pregnancies and transfusion recipient mortality: A role for red blood cell storage?
40. Patient Perspectives on Novel Treatments in Haemophilia: A Qualitative Study
41. Preterm neonates benefit from low prophylactic platelet transfusion threshold despite varying risk of bleeding or death
42. Predictive value of a bleeding score for postpartum hemorrhage
43. Fluid resuscitation during persistent postpartum haemorrhage and maternal outcome: A nationwide cohort study
44. Type 1 VWD classification revisited - novel insights from combined analysis of the LoVIC and WiN studies
45. Additional Strategies to Minimize Blood Loss in Babies Born Very Preterm
46. Coagulation parameters during the course of severe postpartum hemorrhage: a nationwide retrospective cohort study
47. Hemostatic efficacy of pathogen-inactivated vs untreated platelets: a randomized controlled trial
48. Transition readiness among adolescents and young adults with haemophilia in the Netherlands: Nationwide questionnaire study
49. The spectrum of neutralizing and non-neutralizing anti-FVIII antibodies in a nationwide cohort of 788 persons with hemophilia A.
50. Red-blood-cell alloimmunisation in relation to antigens' exposure and their immunogenicity: a cohort study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.